Ulrich Naher - 05 Feb 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: EVP, Chief Commercial Officer
Signature: Jonathan B. Leiken, Attorney in fact for Ulrich Naeher
Issuer symbol: DBD
Transactions as of: 05 Feb 2022
Net transactions value: -$47,000
Form type: 4
Filing time: 08 Feb 2022, 20:15:02 UTC
Previous filing: 07 Feb 2022
Next filing: 10 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBD	Common Shares	Tax liability	$47,000	-5,697	-2.8%	$8.25	200,366	05 Feb 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Options						49,650	05 Feb 2022	Common Shares	49,650	$26.60	Direct	F3
holding	DBD	Non-Qualified Stock Option						30,278	05 Feb 2022	Common Shares	30,278	$18.75	Direct	F4
holding	DBD	Non-Qualified Stock Option						47,407	05 Feb 2022	Common Shares	47,407	$4.08	Direct	F4
holding	DBD	Non-Qualified Stock Option						12,614	05 Feb 2022	Common Shares	12,614	$11.96	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld pursuant to exercise of tax withholding right under the 2017 Equity and Performance Incentive Plan - Restricted Share Award
F2	Number includes restricted stock units.
F3	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.